Amble Health

No telehealth services are confirmed to still safely offer compounded GLP-1s after the FDA’s March 2026 and June 2026 crackdowns, as major companies—including Ro, Hims & Hers, Good Life, and others—have either stopped offering them entirely or transitioned to FDA-approved alternatives like Wegovy, Zepbound, and Saxenda. The FDA issued 30 warning letters in March 2026 and 25 additional warning letters in June 2026 to telehealth companies for falsely or misleadingly marketing compounded GLP-1 products, which the agency explicitly states are not FDA-approved and lack proven safety, efficacy, or consistent quality [1][2][3][4]. Most prominent healthcare providers now either prescribe compounded medications only when legally permitted (e.g., for allergies or unavailable dosages) or have eliminated compounded GLP-1 use altogether [2]. If you are seeking weight-loss treatment, the safest and most reliable options are currently: Wegovy (Novo Nordisk) – FDA-approved for chronic weight management [2] Zepbound (Eli Lilly) – FDA-approved for weight loss [2] Saxenda (Novo Nordisk) – FDA-approved, often used with generics [2] For access to these, consult licensed telehealth platforms that now focus on approved medications, such as: Ro (now offers Wegovy and Zepbound) Hims & Hers (shifted to FDA-approved GLP-1s) Amble Health (mentioned in context, but verify current offerings) [5] Always verify a company’s compliance status on the FDA’s Warning Letters page before signing up, as enforcement remains aggressive and ongoing [1][3].

Mentioned in position 9 of 9

Several telehealth services still appear to offer compounded GLP-1s, but the landscape changed sharply after the FDA’s March 2026 warning letters, and some companies have already shifted to branded products or stopped compounded offerings altogether.[4][2][3] Based on the sources you provided, the clearest names that were still associated with compounded GLP-1 access are: Hims & Hers — cited by CNBC as a company the FDA targeted and as still marketing a compounded GLP-1 offering at that time.[6] Amble Health — KFF Health News reported a patient receiving a GLP-1 prescription through Amble Health via online intake.[2] SkinnyRx — named by KFF as one of the telehealth companies receiving FDA warning letters.[2] Join Josie — named by KFF as another warned telehealth company.[2] Genesis Health International — also named by KFF among warned companies.[2] Lovely Meds — identified by STAT as one of the warned telehealth companies marketing compounded weight-loss drugs.[3] Hello Cake — identified by STAT as one of the warned telehealth companies.[3] MEDVi — identified by STAT as one of the warned telehealth companies.[3] A more important distinction: being named in a warning letter does not necessarily mean the company stopped offering compounded GLP-1s, only that the FDA believed its marketing was misleading or improper.[4][3] Some larger telehealth brands have reportedly moved away from compounded versions and toward FDA-approved branded medications like Wegovy or Zepbound instead.[2] If you want, I can also give you a current shortlist of telehealth companies most likely still offering compounded GLP-1s as of mid-2026, separated into: still likely active likely stopped too risky / under FDA scrutiny

Mentioned in position 2 of 8

Some telehealth services still offer compounded GLP-1s, but availability has narrowed and the FDA has specifically warned 30 telehealth companies against illegally marketing compounded GLP-1 products.[3] Compounded versions are not FDA-approved, and the FDA said the companies cited were making false or misleading claims about them.[3] From the search results, the telehealth brands/services explicitly mentioned as still involved with compounded GLP-1 access include: Amble Health — reported by KFF Health News as a telehealth company a patient used to obtain a GLP-1 after an online form.[1] Hims & Hers — named by the FDA among companies that received warning letters over compounded weight-loss drug claims.[1][3] SkinnyRx — also named in the FDA warning-letter sweep.[1][3] Join Josie — named in the FDA warning-letter sweep.[1][3] Genesis Health International — named in the FDA warning-letter sweep.[1][3] A practical takeaway is that some telehealth companies may still prescribe or facilitate compounded GLP-1s through compounding pharmacies, but the FDA crackdown means you should expect stricter sourcing, more warnings, and more companies exiting this market.[1][3][5] If you want, I can also give you a current shortlist of telehealth services that are still offering GLP-1s as of 2026, separated into: compounded GLP-1s brand-name Ozempic/Wegovy/Zepbound access most reputable options

Mentioned in position 1 of 5